Development of multiple cutaneous immune-related adverse events among cancer patients after immune checkpoint blockade: Supplemental File

These files discuss additional methodological details and include two supplemental tables, the first summarizing cirAE characteristics in patients who developed multiple cirAEs after ICI therapy, and the second describing demographic and baseline clinical characteristics of all patients.本部分文件详述了补充方法学细节，并包含两份补充表格：第一份表格汇总了免疫检查点抑制剂（immune checkpoint inhibitor，ICI）治疗后出现多重cirAE（cirAE）的受试者的cirAE特征；第二份表格则描述了全部受试者的人口统计学特征与基线临床特征。